June 27, 2023 Comments Off on New patent for Boehringer Ingelheim drug JENTADUETO XR Posted in: Patent Added Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Boehringer Ingelheim drug JENTADUETO XR appe…
June 27, 2023 Comments Off on New patent for Boehringer Ingelheim drug GLYXAMBI Posted in: Patent Added Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent for Boehringer Ingelheim drug GLYXAMBI appear…
